[Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components]

L A Strizhakov1, S Yu Karpov1, V V Fomin1

  • 1I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia.

Insights

Chronic hepatitis C (CHC) can cause heart injury. This review explores how the hepatitis C virus directly and immunologically impacts the heart, leading to myocarditis and cardiomyopathies.

Area of Science:

  • Cardiology
  • Hepatology
  • Virology

Background:

  • Heart injury is a recognized extrahepatic manifestation of chronic hepatitis C (CHC).
  • Existing literature highlights a significant association between CHC and myocardial injury.
  • Understanding this link is crucial for comprehensive patient management.

Purpose of the Study:

  • To review and synthesize data on the relationship between CHC and myocardial injury.
  • To elucidate the pathogenetic mechanisms by which hepatitis C virus (HCV) affects the heart.
  • To discuss the role of viral and immunological factors in HCV-induced cardiac conditions.

Main Methods:

  • Literature review of Russian and international studies.
  • Analysis of pathogenetic pathways.
  • Synthesis of data on viral and immunological components.

Main Results:

  • Hepatitis C virus can directly impact myocardial tissue.
  • Immunological responses triggered by HCV contribute to cardiac damage.
  • These mechanisms can lead to the development of myocarditis and cardiomyopathies in CHC patients.

Conclusions:

  • CHC is associated with significant myocardial injury through direct viral effects and immune-mediated pathways.
  • HCV infection can induce inflammatory and degenerative heart conditions.
  • Further research into these mechanisms may inform therapeutic strategies for cardiac complications in CHC.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
493
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
535
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568